| Water Retention | |
|---|---|
| Hepatotoxicity | |
| Lab Test | Anti-Xa assay can be used to measure the pharmacodynamic effects |
| Strength | |
| Also known as | |
| Blood pressure | |
| Trade name | |
| Storage conditions | |
| Chemical name | |
| Formula | |
| Substance class | |
| Main action | |
| Half-life | |
| Dosage (medical) | Typically 5 mg twice daily, may vary based on renal function and patient characteristics |
| Dosage (sports) | |
| Effects | Reduces the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation |
| Side effects | |
| Use in sports | Not commonly used in sports, no performance-enhancing benefits |
| Manufacturer |
Eliquis 5 mg Pfizer
£152.00